• レポートコード:QY2207E10471 • 出版社/出版日:QYResearch / 2022年7月 • レポート形態:英文、PDF、87ページ • 納品方法:Eメール(納期:3日) • 産業分類:医薬品 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,102,500 (USD7,350) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の陽性アロステリック調節因子(PAM)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に陽性アロステリック調節因子(PAM)の世界市場のxxx%を占める「ベンゾジアゼピン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「パーキンソン病」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。 中国の陽性アロステリック調節因子(PAM)の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの陽性アロステリック調節因子(PAM)市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの陽性アロステリック調節因子(PAM)市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。 陽性アロステリック調節因子(PAM)のグローバル主要メーカーには、F. Hoffmann-La Roche、Pfizer、Taj Pharmaceuticals、Explicit Chemicals、Shaanxi Rebecca Bio-Tech、Zydus Cadila、ACADIA Pharmaceuticals、M Somerset Pharmaceuticals、Vertical Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。 陽性アロステリック調節因子(PAM)市場は、種類と用途によって区分されます。世界の陽性アロステリック調節因子(PAM)市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ベンゾジアゼピン、バルビツール酸塩、アマンタジン、その他 【用途別セグメント】 パーキンソン病、統合失調症、アルツハイマー病 【掲載地域】 北米:アメリカ、カナダ ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米:メキシコ、ブラジル、アルゼンチン 中東・アフリカ:トルコ、サウジアラビア、UAE 【目次(一部)】 ・調査の範囲 - 陽性アロステリック調節因子(PAM)製品概要 - 種類別市場(ベンゾジアゼピン、バルビツール酸塩、アマンタジン、その他) - 用途別市場(パーキンソン病、統合失調症、アルツハイマー病) - 調査の目的 ・エグゼクティブサマリー - 世界の陽性アロステリック調節因子(PAM)販売量予測2017-2028 - 世界の陽性アロステリック調節因子(PAM)売上予測2017-2028 - 陽性アロステリック調節因子(PAM)の地域別販売量 - 陽性アロステリック調節因子(PAM)の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別陽性アロステリック調節因子(PAM)販売量 - 主要メーカー別陽性アロステリック調節因子(PAM)売上 - 主要メーカー別陽性アロステリック調節因子(PAM)価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模(ベンゾジアゼピン、バルビツール酸塩、アマンタジン、その他) - 陽性アロステリック調節因子(PAM)の種類別販売量 - 陽性アロステリック調節因子(PAM)の種類別売上 - 陽性アロステリック調節因子(PAM)の種類別価格 ・用途別市場規模(パーキンソン病、統合失調症、アルツハイマー病) - 陽性アロステリック調節因子(PAM)の用途別販売量 - 陽性アロステリック調節因子(PAM)の用途別売上 - 陽性アロステリック調節因子(PAM)の用途別価格 ・北米市場 - 北米の陽性アロステリック調節因子(PAM)市場規模(種類別、用途別) - 主要国別の陽性アロステリック調節因子(PAM)市場規模(アメリカ、カナダ) ・ヨーロッパ市場 - ヨーロッパの陽性アロステリック調節因子(PAM)市場規模(種類別、用途別) - 主要国別の陽性アロステリック調節因子(PAM)市場規模(ドイツ、フランス、イギリス、イタリア、ロシア) ・アジア太平洋市場 - アジア太平洋の陽性アロステリック調節因子(PAM)市場規模(種類別、用途別) - 主要国別の陽性アロステリック調節因子(PAM)市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア) ・中南米市場 - 中南米の陽性アロステリック調節因子(PAM)市場規模(種類別、用途別) - 主要国別の陽性アロステリック調節因子(PAM)市場規模(メキシコ、ブラジル、アルゼンチン) ・中東・アフリカ市場 - 中東・アフリカの陽性アロステリック調節因子(PAM)市場規模(種類別、用途別) - 主要国別の陽性アロステリック調節因子(PAM)市場規模(トルコ、サウジアラビア) ・企業情報 F. Hoffmann-La Roche、Pfizer、Taj Pharmaceuticals、Explicit Chemicals、Shaanxi Rebecca Bio-Tech、Zydus Cadila、ACADIA Pharmaceuticals、M Somerset Pharmaceuticals、Vertical Pharmaceuticals ・産業チェーン及び販売チャネル分析 - 陽性アロステリック調節因子(PAM)の産業チェーン分析 - 陽性アロステリック調節因子(PAM)の原材料 - 陽性アロステリック調節因子(PAM)の生産プロセス - 陽性アロステリック調節因子(PAM)の販売及びマーケティング - 陽性アロステリック調節因子(PAM)の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 陽性アロステリック調節因子(PAM)の産業動向 - 陽性アロステリック調節因子(PAM)のマーケットドライバー - 陽性アロステリック調節因子(PAM)の課題 - 陽性アロステリック調節因子(PAM)の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Positive Allosteric Modulators Market
Due to the COVID-19 pandemic, the global Positive Allosteric Modulators market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Benzodiazepines accounting for % of the Positive Allosteric Modulators global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Parkinson’s Disease segment is altered to an % CAGR throughout this forecast period.
China Positive Allosteric Modulators market size is valued at US$ million in 2021, while the US and Europe Positive Allosteric Modulators are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Positive Allosteric Modulators landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Positive Allosteric Modulators include F. Hoffmann-La Roche, Pfizer, Taj Pharmaceuticals, Explicit Chemicals, Shaanxi Rebecca Bio-Tech, Zydus Cadila, ACADIA Pharmaceuticals, M Somerset Pharmaceuticals and Vertical Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Positive Allosteric Modulators Scope and Segment
Positive Allosteric Modulators market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Positive Allosteric Modulators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Benzodiazepines
Barbiturates
Amantadine
Other
Segment by Application
Parkinson’s Disease
Schizophrenia
Alzheimer’s Disease
By Company
F. Hoffmann-La Roche
Pfizer
Taj Pharmaceuticals
Explicit Chemicals
Shaanxi Rebecca Bio-Tech
Zydus Cadila
ACADIA Pharmaceuticals
M Somerset Pharmaceuticals
Vertical Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Positive Allosteric Modulators Product Introduction
1.2 Market by Type
1.2.1 Global Positive Allosteric Modulators Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Benzodiazepines
1.2.3 Barbiturates
1.2.4 Amantadine
1.2.5 Other
1.3 Market by Application
1.3.1 Global Positive Allosteric Modulators Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Parkinson’s Disease
1.3.3 Schizophrenia
1.3.4 Alzheimer’s Disease
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Positive Allosteric Modulators Sales Estimates and Forecasts 2017-2028
2.2 Global Positive Allosteric Modulators Revenue Estimates and Forecasts 2017-2028
2.3 Global Positive Allosteric Modulators Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Positive Allosteric Modulators Sales by Region
2.4.1 Global Positive Allosteric Modulators Sales by Region (2017-2022)
2.4.2 Global Sales Positive Allosteric Modulators by Region (2023-2028)
2.5 Global Positive Allosteric Modulators Revenue by Region
2.5.1 Global Positive Allosteric Modulators Revenue by Region (2017-2022)
2.5.2 Global Positive Allosteric Modulators Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Positive Allosteric Modulators Sales by Manufacturers
3.1.1 Global Top Positive Allosteric Modulators Manufacturers by Sales (2017-2022)
3.1.2 Global Positive Allosteric Modulators Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Positive Allosteric Modulators in 2021
3.2 Global Positive Allosteric Modulators Revenue by Manufacturers
3.2.1 Global Positive Allosteric Modulators Revenue by Manufacturers (2017-2022)
3.2.2 Global Positive Allosteric Modulators Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Positive Allosteric Modulators Revenue in 2021
3.3 Global Positive Allosteric Modulators Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Positive Allosteric Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Positive Allosteric Modulators Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Positive Allosteric Modulators Sales by Type
4.1.1 Global Positive Allosteric Modulators Historical Sales by Type (2017-2022)
4.1.2 Global Positive Allosteric Modulators Forecasted Sales by Type (2023-2028)
4.1.3 Global Positive Allosteric Modulators Sales Market Share by Type (2017-2028)
4.2 Global Positive Allosteric Modulators Revenue by Type
4.2.1 Global Positive Allosteric Modulators Historical Revenue by Type (2017-2022)
4.2.2 Global Positive Allosteric Modulators Forecasted Revenue by Type (2023-2028)
4.2.3 Global Positive Allosteric Modulators Revenue Market Share by Type (2017-2028)
4.3 Global Positive Allosteric Modulators Price by Type
4.3.1 Global Positive Allosteric Modulators Price by Type (2017-2022)
4.3.2 Global Positive Allosteric Modulators Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Positive Allosteric Modulators Sales by Application
5.1.1 Global Positive Allosteric Modulators Historical Sales by Application (2017-2022)
5.1.2 Global Positive Allosteric Modulators Forecasted Sales by Application (2023-2028)
5.1.3 Global Positive Allosteric Modulators Sales Market Share by Application (2017-2028)
5.2 Global Positive Allosteric Modulators Revenue by Application
5.2.1 Global Positive Allosteric Modulators Historical Revenue by Application (2017-2022)
5.2.2 Global Positive Allosteric Modulators Forecasted Revenue by Application (2023-2028)
5.2.3 Global Positive Allosteric Modulators Revenue Market Share by Application (2017-2028)
5.3 Global Positive Allosteric Modulators Price by Application
5.3.1 Global Positive Allosteric Modulators Price by Application (2017-2022)
5.3.2 Global Positive Allosteric Modulators Price Forecast by Application (2023-2028)
6 North America
6.1 North America Positive Allosteric Modulators Market Size by Type
6.1.1 North America Positive Allosteric Modulators Sales by Type (2017-2028)
6.1.2 North America Positive Allosteric Modulators Revenue by Type (2017-2028)
6.2 North America Positive Allosteric Modulators Market Size by Application
6.2.1 North America Positive Allosteric Modulators Sales by Application (2017-2028)
6.2.2 North America Positive Allosteric Modulators Revenue by Application (2017-2028)
6.3 North America Positive Allosteric Modulators Market Size by Country
6.3.1 North America Positive Allosteric Modulators Sales by Country (2017-2028)
6.3.2 North America Positive Allosteric Modulators Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Positive Allosteric Modulators Market Size by Type
7.1.1 Europe Positive Allosteric Modulators Sales by Type (2017-2028)
7.1.2 Europe Positive Allosteric Modulators Revenue by Type (2017-2028)
7.2 Europe Positive Allosteric Modulators Market Size by Application
7.2.1 Europe Positive Allosteric Modulators Sales by Application (2017-2028)
7.2.2 Europe Positive Allosteric Modulators Revenue by Application (2017-2028)
7.3 Europe Positive Allosteric Modulators Market Size by Country
7.3.1 Europe Positive Allosteric Modulators Sales by Country (2017-2028)
7.3.2 Europe Positive Allosteric Modulators Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Positive Allosteric Modulators Market Size by Type
8.1.1 Asia Pacific Positive Allosteric Modulators Sales by Type (2017-2028)
8.1.2 Asia Pacific Positive Allosteric Modulators Revenue by Type (2017-2028)
8.2 Asia Pacific Positive Allosteric Modulators Market Size by Application
8.2.1 Asia Pacific Positive Allosteric Modulators Sales by Application (2017-2028)
8.2.2 Asia Pacific Positive Allosteric Modulators Revenue by Application (2017-2028)
8.3 Asia Pacific Positive Allosteric Modulators Market Size by Region
8.3.1 Asia Pacific Positive Allosteric Modulators Sales by Region (2017-2028)
8.3.2 Asia Pacific Positive Allosteric Modulators Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Positive Allosteric Modulators Market Size by Type
9.1.1 Latin America Positive Allosteric Modulators Sales by Type (2017-2028)
9.1.2 Latin America Positive Allosteric Modulators Revenue by Type (2017-2028)
9.2 Latin America Positive Allosteric Modulators Market Size by Application
9.2.1 Latin America Positive Allosteric Modulators Sales by Application (2017-2028)
9.2.2 Latin America Positive Allosteric Modulators Revenue by Application (2017-2028)
9.3 Latin America Positive Allosteric Modulators Market Size by Country
9.3.1 Latin America Positive Allosteric Modulators Sales by Country (2017-2028)
9.3.2 Latin America Positive Allosteric Modulators Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Positive Allosteric Modulators Market Size by Type
10.1.1 Middle East and Africa Positive Allosteric Modulators Sales by Type (2017-2028)
10.1.2 Middle East and Africa Positive Allosteric Modulators Revenue by Type (2017-2028)
10.2 Middle East and Africa Positive Allosteric Modulators Market Size by Application
10.2.1 Middle East and Africa Positive Allosteric Modulators Sales by Application (2017-2028)
10.2.2 Middle East and Africa Positive Allosteric Modulators Revenue by Application (2017-2028)
10.3 Middle East and Africa Positive Allosteric Modulators Market Size by Country
10.3.1 Middle East and Africa Positive Allosteric Modulators Sales by Country (2017-2028)
10.3.2 Middle East and Africa Positive Allosteric Modulators Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Overview
11.1.3 F. Hoffmann-La Roche Positive Allosteric Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 F. Hoffmann-La Roche Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Positive Allosteric Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Taj Pharmaceuticals
11.3.1 Taj Pharmaceuticals Corporation Information
11.3.2 Taj Pharmaceuticals Overview
11.3.3 Taj Pharmaceuticals Positive Allosteric Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Taj Pharmaceuticals Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Taj Pharmaceuticals Recent Developments
11.4 Explicit Chemicals
11.4.1 Explicit Chemicals Corporation Information
11.4.2 Explicit Chemicals Overview
11.4.3 Explicit Chemicals Positive Allosteric Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Explicit Chemicals Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Explicit Chemicals Recent Developments
11.5 Shaanxi Rebecca Bio-Tech
11.5.1 Shaanxi Rebecca Bio-Tech Corporation Information
11.5.2 Shaanxi Rebecca Bio-Tech Overview
11.5.3 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Shaanxi Rebecca Bio-Tech Recent Developments
11.6 Zydus Cadila
11.6.1 Zydus Cadila Corporation Information
11.6.2 Zydus Cadila Overview
11.6.3 Zydus Cadila Positive Allosteric Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Zydus Cadila Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zydus Cadila Recent Developments
11.7 ACADIA Pharmaceuticals
11.7.1 ACADIA Pharmaceuticals Corporation Information
11.7.2 ACADIA Pharmaceuticals Overview
11.7.3 ACADIA Pharmaceuticals Positive Allosteric Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ACADIA Pharmaceuticals Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ACADIA Pharmaceuticals Recent Developments
11.8 M Somerset Pharmaceuticals
11.8.1 M Somerset Pharmaceuticals Corporation Information
11.8.2 M Somerset Pharmaceuticals Overview
11.8.3 M Somerset Pharmaceuticals Positive Allosteric Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 M Somerset Pharmaceuticals Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 M Somerset Pharmaceuticals Recent Developments
11.9 Vertical Pharmaceuticals
11.9.1 Vertical Pharmaceuticals Corporation Information
11.9.2 Vertical Pharmaceuticals Overview
11.9.3 Vertical Pharmaceuticals Positive Allosteric Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Vertical Pharmaceuticals Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vertical Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Positive Allosteric Modulators Industry Chain Analysis
12.2 Positive Allosteric Modulators Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Positive Allosteric Modulators Production Mode & Process
12.4 Positive Allosteric Modulators Sales and Marketing
12.4.1 Positive Allosteric Modulators Sales Channels
12.4.2 Positive Allosteric Modulators Distributors
12.5 Positive Allosteric Modulators Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Positive Allosteric Modulators Industry Trends
13.2 Positive Allosteric Modulators Market Drivers
13.3 Positive Allosteric Modulators Market Challenges
13.4 Positive Allosteric Modulators Market Restraints
14 Key Findings in The Global Positive Allosteric Modulators Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Positive Allosteric Modulators Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Benzodiazepines
Table 3. Major Manufacturers of Barbiturates
Table 4. Major Manufacturers of Amantadine
Table 5. Major Manufacturers of Other
Table 6. Global Positive Allosteric Modulators Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Positive Allosteric Modulators Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Positive Allosteric Modulators Sales by Region (2017-2022) & (Kiloton)
Table 9. Global Positive Allosteric Modulators Sales Market Share by Region (2017-2022)
Table 10. Global Positive Allosteric Modulators Sales by Region (2023-2028) & (Kiloton)
Table 11. Global Positive Allosteric Modulators Sales Market Share by Region (2023-2028)
Table 12. Global Positive Allosteric Modulators Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Positive Allosteric Modulators Revenue Market Share by Region (2017-2022)
Table 14. Global Positive Allosteric Modulators Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Positive Allosteric Modulators Revenue Market Share by Region (2023-2028)
Table 16. Global Positive Allosteric Modulators Sales by Manufacturers (2017-2022) & (Kiloton)
Table 17. Global Positive Allosteric Modulators Sales Share by Manufacturers (2017-2022)
Table 18. Global Positive Allosteric Modulators Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Positive Allosteric Modulators Revenue Share by Manufacturers (2017-2022)
Table 20. Positive Allosteric Modulators Price by Manufacturers (2017-2022) &(US$/Ton)
Table 21. Global Positive Allosteric Modulators Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Positive Allosteric Modulators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Positive Allosteric Modulators as of 2021)
Table 23. Positive Allosteric Modulators Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Positive Allosteric Modulators Product Offered
Table 25. Date of Manufacturers Enter into Positive Allosteric Modulators Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Positive Allosteric Modulators Sales by Type (2017-2022) & (Kiloton)
Table 28. Global Positive Allosteric Modulators Sales by Type (2023-2028) & (Kiloton)
Table 29. Global Positive Allosteric Modulators Sales Share by Type (2017-2022)
Table 30. Global Positive Allosteric Modulators Sales Share by Type (2023-2028)
Table 31. Global Positive Allosteric Modulators Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Positive Allosteric Modulators Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Positive Allosteric Modulators Revenue Share by Type (2017-2022)
Table 34. Global Positive Allosteric Modulators Revenue Share by Type (2023-2028)
Table 35. Positive Allosteric Modulators Price by Type (2017-2022) & (US$/Ton)
Table 36. Global Positive Allosteric Modulators Price Forecast by Type (2023-2028) & (US$/Ton)
Table 37. Global Positive Allosteric Modulators Sales by Application (2017-2022) & (Kiloton)
Table 38. Global Positive Allosteric Modulators Sales by Application (2023-2028) & (Kiloton)
Table 39. Global Positive Allosteric Modulators Sales Share by Application (2017-2022)
Table 40. Global Positive Allosteric Modulators Sales Share by Application (2023-2028)
Table 41. Global Positive Allosteric Modulators Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Positive Allosteric Modulators Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Positive Allosteric Modulators Revenue Share by Application (2017-2022)
Table 44. Global Positive Allosteric Modulators Revenue Share by Application (2023-2028)
Table 45. Positive Allosteric Modulators Price by Application (2017-2022) & (US$/Ton)
Table 46. Global Positive Allosteric Modulators Price Forecast by Application (2023-2028) & (US$/Ton)
Table 47. North America Positive Allosteric Modulators Sales by Type (2017-2022) & (Kiloton)
Table 48. North America Positive Allosteric Modulators Sales by Type (2023-2028) & (Kiloton)
Table 49. North America Positive Allosteric Modulators Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Positive Allosteric Modulators Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Positive Allosteric Modulators Sales by Application (2017-2022) & (Kiloton)
Table 52. North America Positive Allosteric Modulators Sales by Application (2023-2028) & (Kiloton)
Table 53. North America Positive Allosteric Modulators Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Positive Allosteric Modulators Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Positive Allosteric Modulators Sales by Country (2017-2022) & (Kiloton)
Table 56. North America Positive Allosteric Modulators Sales by Country (2023-2028) & (Kiloton)
Table 57. North America Positive Allosteric Modulators Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Positive Allosteric Modulators Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Positive Allosteric Modulators Sales by Type (2017-2022) & (Kiloton)
Table 60. Europe Positive Allosteric Modulators Sales by Type (2023-2028) & (Kiloton)
Table 61. Europe Positive Allosteric Modulators Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Positive Allosteric Modulators Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Positive Allosteric Modulators Sales by Application (2017-2022) & (Kiloton)
Table 64. Europe Positive Allosteric Modulators Sales by Application (2023-2028) & (Kiloton)
Table 65. Europe Positive Allosteric Modulators Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Positive Allosteric Modulators Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Positive Allosteric Modulators Sales by Country (2017-2022) & (Kiloton)
Table 68. Europe Positive Allosteric Modulators Sales by Country (2023-2028) & (Kiloton)
Table 69. Europe Positive Allosteric Modulators Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Positive Allosteric Modulators Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Positive Allosteric Modulators Sales by Type (2017-2022) & (Kiloton)
Table 72. Asia Pacific Positive Allosteric Modulators Sales by Type (2023-2028) & (Kiloton)
Table 73. Asia Pacific Positive Allosteric Modulators Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Positive Allosteric Modulators Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Positive Allosteric Modulators Sales by Application (2017-2022) & (Kiloton)
Table 76. Asia Pacific Positive Allosteric Modulators Sales by Application (2023-2028) & (Kiloton)
Table 77. Asia Pacific Positive Allosteric Modulators Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Positive Allosteric Modulators Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Positive Allosteric Modulators Sales by Region (2017-2022) & (Kiloton)
Table 80. Asia Pacific Positive Allosteric Modulators Sales by Region (2023-2028) & (Kiloton)
Table 81. Asia Pacific Positive Allosteric Modulators Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Positive Allosteric Modulators Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Positive Allosteric Modulators Sales by Type (2017-2022) & (Kiloton)
Table 84. Latin America Positive Allosteric Modulators Sales by Type (2023-2028) & (Kiloton)
Table 85. Latin America Positive Allosteric Modulators Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Positive Allosteric Modulators Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Positive Allosteric Modulators Sales by Application (2017-2022) & (Kiloton)
Table 88. Latin America Positive Allosteric Modulators Sales by Application (2023-2028) & (Kiloton)
Table 89. Latin America Positive Allosteric Modulators Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Positive Allosteric Modulators Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Positive Allosteric Modulators Sales by Country (2017-2022) & (Kiloton)
Table 92. Latin America Positive Allosteric Modulators Sales by Country (2023-2028) & (Kiloton)
Table 93. Latin America Positive Allosteric Modulators Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Positive Allosteric Modulators Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Positive Allosteric Modulators Sales by Type (2017-2022) & (Kiloton)
Table 96. Middle East and Africa Positive Allosteric Modulators Sales by Type (2023-2028) & (Kiloton)
Table 97. Middle East and Africa Positive Allosteric Modulators Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Positive Allosteric Modulators Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Positive Allosteric Modulators Sales by Application (2017-2022) & (Kiloton)
Table 100. Middle East and Africa Positive Allosteric Modulators Sales by Application (2023-2028) & (Kiloton)
Table 101. Middle East and Africa Positive Allosteric Modulators Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Positive Allosteric Modulators Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Positive Allosteric Modulators Sales by Country (2017-2022) & (Kiloton)
Table 104. Middle East and Africa Positive Allosteric Modulators Sales by Country (2023-2028) & (Kiloton)
Table 105. Middle East and Africa Positive Allosteric Modulators Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Positive Allosteric Modulators Revenue by Country (2023-2028) & (US$ Million)
Table 107. F. Hoffmann-La Roche Corporation Information
Table 108. F. Hoffmann-La Roche Description and Major Businesses
Table 109. F. Hoffmann-La Roche Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 110. F. Hoffmann-La Roche Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. F. Hoffmann-La Roche Recent Developments
Table 112. Pfizer Corporation Information
Table 113. Pfizer Description and Major Businesses
Table 114. Pfizer Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Pfizer Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pfizer Recent Developments
Table 117. Taj Pharmaceuticals Corporation Information
Table 118. Taj Pharmaceuticals Description and Major Businesses
Table 119. Taj Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Taj Pharmaceuticals Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Taj Pharmaceuticals Recent Developments
Table 122. Explicit Chemicals Corporation Information
Table 123. Explicit Chemicals Description and Major Businesses
Table 124. Explicit Chemicals Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Explicit Chemicals Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Explicit Chemicals Recent Developments
Table 127. Shaanxi Rebecca Bio-Tech Corporation Information
Table 128. Shaanxi Rebecca Bio-Tech Description and Major Businesses
Table 129. Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Shaanxi Rebecca Bio-Tech Recent Developments
Table 132. Zydus Cadila Corporation Information
Table 133. Zydus Cadila Description and Major Businesses
Table 134. Zydus Cadila Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Zydus Cadila Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Zydus Cadila Recent Developments
Table 137. ACADIA Pharmaceuticals Corporation Information
Table 138. ACADIA Pharmaceuticals Description and Major Businesses
Table 139. ACADIA Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. ACADIA Pharmaceuticals Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. ACADIA Pharmaceuticals Recent Developments
Table 142. M Somerset Pharmaceuticals Corporation Information
Table 143. M Somerset Pharmaceuticals Description and Major Businesses
Table 144. M Somerset Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. M Somerset Pharmaceuticals Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. M Somerset Pharmaceuticals Recent Developments
Table 147. Vertical Pharmaceuticals Corporation Information
Table 148. Vertical Pharmaceuticals Description and Major Businesses
Table 149. Vertical Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 150. Vertical Pharmaceuticals Positive Allosteric Modulators Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Vertical Pharmaceuticals Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Positive Allosteric Modulators Distributors List
Table 155. Positive Allosteric Modulators Customers List
Table 156. Positive Allosteric Modulators Market Trends
Table 157. Positive Allosteric Modulators Market Drivers
Table 158. Positive Allosteric Modulators Market Challenges
Table 159. Positive Allosteric Modulators Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Positive Allosteric Modulators Product Picture
Figure 3. Global Positive Allosteric Modulators Market Share by Type in 2021 & 2028
Figure 3. Benzodiazepines Product Picture
Figure 4. Barbiturates Product Picture
Figure 5. Amantadine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Positive Allosteric Modulators Market Share by Application in 2021 & 2028
Figure 8. Parkinson’s Disease
Figure 9. Schizophrenia
Figure 10. Alzheimer’s Disease
Figure 11. Positive Allosteric Modulators Report Years Considered
Figure 12. Global Positive Allosteric Modulators Sales 2017-2028 (Kiloton)
Figure 13. Global Positive Allosteric Modulators Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Positive Allosteric Modulators Revenue 2017-2028 (US$ Million)
Figure 15. Global Positive Allosteric Modulators Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Positive Allosteric Modulators Sales Market Share by Region (2017-2022)
Figure 17. Global Positive Allosteric Modulators Sales Market Share by Region (2023-2028)
Figure 18. North America Positive Allosteric Modulators Sales YoY (2017-2028) & (Kiloton)
Figure 19. North America Positive Allosteric Modulators Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Positive Allosteric Modulators Sales YoY (2017-2028) & (Kiloton)
Figure 21. Europe Positive Allosteric Modulators Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Positive Allosteric Modulators Sales YoY (2017-2028) & (Kiloton)
Figure 23. Asia-Pacific Positive Allosteric Modulators Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Positive Allosteric Modulators Sales YoY (2017-2028) & (Kiloton)
Figure 25. Latin America Positive Allosteric Modulators Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Positive Allosteric Modulators Sales YoY (2017-2028) & (Kiloton)
Figure 27. Middle East & Africa Positive Allosteric Modulators Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Positive Allosteric Modulators Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Positive Allosteric Modulators in the World: Market Share by Positive Allosteric Modulators Revenue in 2021
Figure 30. Global Positive Allosteric Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Positive Allosteric Modulators Sales Market Share by Type (2017-2028)
Figure 32. Global Positive Allosteric Modulators Revenue Market Share by Type (2017-2028)
Figure 33. Global Positive Allosteric Modulators Sales Market Share by Application (2017-2028)
Figure 34. Global Positive Allosteric Modulators Revenue Market Share by Application (2017-2028)
Figure 35. North America Positive Allosteric Modulators Sales Market Share by Type (2017-2028)
Figure 36. North America Positive Allosteric Modulators Revenue Market Share by Type (2017-2028)
Figure 37. North America Positive Allosteric Modulators Sales Market Share by Application (2017-2028)
Figure 38. North America Positive Allosteric Modulators Revenue Market Share by Application (2017-2028)
Figure 39. North America Positive Allosteric Modulators Sales Share by Country (2017-2028)
Figure 40. North America Positive Allosteric Modulators Revenue Share by Country (2017-2028)
Figure 41. United States Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Positive Allosteric Modulators Sales Market Share by Type (2017-2028)
Figure 44. Europe Positive Allosteric Modulators Revenue Market Share by Type (2017-2028)
Figure 45. Europe Positive Allosteric Modulators Sales Market Share by Application (2017-2028)
Figure 46. Europe Positive Allosteric Modulators Revenue Market Share by Application (2017-2028)
Figure 47. Europe Positive Allosteric Modulators Sales Share by Country (2017-2028)
Figure 48. Europe Positive Allosteric Modulators Revenue Share by Country (2017-2028)
Figure 49. Germany Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 50. France Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Positive Allosteric Modulators Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Positive Allosteric Modulators Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Positive Allosteric Modulators Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Positive Allosteric Modulators Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Positive Allosteric Modulators Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Positive Allosteric Modulators Revenue Share by Region (2017-2028)
Figure 60. China Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 63. India Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Positive Allosteric Modulators Sales Market Share by Type (2017-2028)
Figure 70. Latin America Positive Allosteric Modulators Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Positive Allosteric Modulators Sales Market Share by Application (2017-2028)
Figure 72. Latin America Positive Allosteric Modulators Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Positive Allosteric Modulators Sales Share by Country (2017-2028)
Figure 74. Latin America Positive Allosteric Modulators Revenue Share by Country (2017-2028)
Figure 75. Mexico Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 78. Colombia Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Positive Allosteric Modulators Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Positive Allosteric Modulators Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Positive Allosteric Modulators Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Positive Allosteric Modulators Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Positive Allosteric Modulators Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Positive Allosteric Modulators Revenue Share by Country (2017-2028)
Figure 85. Turkey Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Positive Allosteric Modulators Revenue (2017-2028) & (US$ Million)
Figure 88. Positive Allosteric Modulators Value Chain
Figure 89. Positive Allosteric Modulators Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed